Article
Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Oncotarget - 5 Jul 2016
Wu Jian
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of liver disorders with fat accumulation from simple fatty liver, nonalcoholic steatohepatitis (NASH), fibrosis/cirrhosis and NAFLD/NASH-associated hepatocellular carcinoma (HCC). NASH is a progressive form of NAFLD and requires medical attention. One of 5-10 NASH patients may progress to end-state liver disease (ESLD or cirrhosis) in 5-10 years;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
